NCT05849285

Brief Summary

The population cared for in the Transitional and Lifelong Care (TLC) clinic is youth and adults with childhood-onset disability, of which the large majority are adults with brain-based, neurodevelopmental conditions such as cerebral palsy, spina bifida and developmental disability. The TLC program was created to address the health inequities that have long existed for this population because of the gaps in care they experience once they transition from pediatric healthcare services to the adult healthcare sector. The TLC program offers coordinated and comprehensive management of co-occurring mental, social and physical health conditions for this group of adults with neurodiverse conditions. The proposed study will provide much needed evaluation of the TLC model as an intervention to provide transitional and lifelong care that reduces the barriers experienced because of the undefined clinic path - potentially more appropriately referred to as a "cliff" by a Freeman et al., (2015) - for these individuals. With appropriate evidence of effectiveness, scaling of the TLC program to other Ontario Health regions and more widely across Canada would improve access healthcare providers who are knowledgeable and competent in the management of physical and mental health conditions for adults with neurodiverse conditions as well as service integration and coordination between social and health sectors. The TLC clinic was co-designed with adults with neurodiverse conditions and health care providers in 2014 and represents a significant and sustainable change in the way healthcare has been delivered for this population in the Ontario Health West region over the last 7 years. More than 750 people have accessed coordinated and comprehensive care from Physiatrists, a Nurse Practitioner, Social Worker, Physiotherapist, Occupational Therapist, Speech Language Pathologist, Registered Dietitian and Rehabilitation Therapist in the TLC program since it began, documenting the effectiveness of this care has the power to re-shape care received for adults with neurodiverse conditions that onset in childhood in Canada.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
410

participants targeted

Target at P75+ for all trials

Timeline
20mo left

Started Jan 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress59%
Jan 2024Dec 2027

First Submitted

Initial submission to the registry

April 25, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 8, 2023

Completed
8 months until next milestone

Study Start

First participant enrolled

January 3, 2024

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

February 27, 2026

Status Verified

February 1, 2026

Enrollment Period

3 years

First QC Date

April 25, 2023

Last Update Submit

February 25, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Patient Satisfaction

    MPOC-A (Measure of Processes of Care - Adults) Each domain score, ranging from 0.0 to 7.0, is computed by averaging the ratings for the items of that domain, higher scores represent better outcomes

    Year 1

Secondary Outcomes (5)

  • Health Related Quality of Life (General)

    Year 1

  • Health Related Quality of Life (WHO)

    Year 1

  • Caregiver Burden

    Year 1

  • Perceived Support of Healthcare Providers

    Year 1

  • Economic Analysis

    Year 2

Study Arms (5)

TLC Patient

Patients of the TLC program with CP/SB/DD

Other: TLC Clinic

Control Patient

Adults with CP/SB/DD that are not patients of the TLC Program

TLC Caregiver

Caregiver of Patients of the TLC program with CP/SB/DD

Other: TLC Clinic

Control Caregiver

Caregiver of Adults with CP/SB/DD that are not patients of the TLC Program

Healthcare Providers

Healthcare Providers who care for patients in the TLC clinic

Other: TLC Clinic

Interventions

Patients of the TLC clinic - receive coordinated multidisciplinary and specialized care from a team

Healthcare ProvidersTLC CaregiverTLC Patient

Eligibility Criteria

Age21 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will be categorized into two cohorts: 1) patients of the TLC program, 2) controls . Participant dyads will be formed that include the adult patient (and a caregiver, spouse, or support person that may be involved in the patient's care. TLC dyads will be recruited from the existing client base of the program and control dyads will be recruited from the Kitchener/Waterloo/Cambridge area of Ontario (and the surrounding rural areas).

You may qualify if:

  • Each participant dyad will consist of one person, of either sex and gender, who is over the age of 21 years with a childhood-onset disability, and the primary caregiver (based on contact hours) or support person, of either sex and gender, involved in their care. In cases where the patient participant is independent with care, a spouse or family member may still participate in the caregiver portion of the study.
  • \. Patient participants will have continuously resided in Ontario during the years of 2015 to 2020 to facilitate full data retrieval from the administrative dataset.
  • \. Healthcare providers, of any discipline, who provide care to adults with childhood-onset conditions in the TLC program.

You may not qualify if:

  • Patient participants will be ineligible if they are in a phase of deterioration associated with a progressive health condition identified either personally or by the caregiver participant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Parkwood Institute

London, Ontario, Canada

RECRUITING

MeSH Terms

Conditions

Cerebral PalsySpinal DysraphismDevelopmental Disabilities

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeural Tube DefectsNervous System MalformationsCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNeurodevelopmental DisordersMental Disorders

Study Officials

  • Laura K Brunton, PhD

    Western University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Laura K Brunton, PhD

CONTACT

Josh Wiener, MSc

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 25, 2023

First Posted

May 8, 2023

Study Start

January 3, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 1, 2027

Last Updated

February 27, 2026

Record last verified: 2026-02

Locations